Rhythm sells option to buy GI drug to Activis for $40M
October 22, 2014 at 10:23 AM EDT
Two months, local biotech Rhythm was planning to raise up to $87 million in an initial public offering...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.